Results
Vivanza Biosciences Q2 FY27 Net Profit at ₹3.58 Lakh
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27 ending September 30, 2026.
Standalone Q2 net profit was ₹3.58 lakh with EPS of ₹0.01; H1 profit stood at ₹21.6
